RBOT Company Profile and Key Details

Vicarious Surgical Inc. has 5.30 million shares outstanding. The public float is 3.13 million shares, elevated short interest at 3.63% of float. This equals 130.22 thousand shares. The short ratio is 3.76 days. Institutional investors hold 43.61% of the float. Insiders own 22.63%. Khosla Ventures V, L.P. holds 8.00 million shares, Liang Philip has 730.33 thousand shares and Morris June has 580.18 thousand shares. Over the past six months, insider transactions show net selling. They sold 3.87 thousand shares across 6 transactions.

Vicarious Surgical Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.88. This means the shares are trading below this model’s fair value.

Vicarious Surgical Inc. (NYSE:RBOT) closed at $1.20 USD, gaining $0.20 (20.00%) from the previous close of $1.00. The stock is currently mid-range between its 52-week high and low $0.27 and $13.75. With a market capitalization of about $7.76 million, Vicarious Surgical Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.55). Key stats such as the average daily volume over the past year has been around 117.62 thousand shares, volume is running light vs its 52-week average. Headquartered in Waltham, MA, Vicarious Surgical Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Stephen From, the company employs approximately 123 people and listed since September 04, 2020. Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery.

Our AI price prediction model suggests that Vicarious Surgical Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -96.67%, with price expected at $0.04 by March 31, 2026, within a range of $0.00 to $0.59 3-Month Outlook: Projected fall of -61.67%, reaching $0.46 by June 15, 2026, with a range of $0.13 to $0.75. 1-Year Outlook: Projected loss of -95.83%, with price at $0.05 by March 17, 2027, within a range of $0.00 to $0.72.

Vicarious Surgical Inc. (NYSE:RBOT) shares are up 18.43% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Vicarious Surgical Inc. trading at a premium to the broader market with a P/E of -0.15. Analyst sentiment is mixed, with the majority of ratings in Neutral territory and a mean price target of $11.86, suggesting 888.33% upside. Our AI forecast model points to short-term weakness (-96.67% over two weeks), a medium-term fall (-61.67% over three months), and a longer-term loss (-95.83% over one year), with expected trading ranges indicating moderate volatility.

Vicarious Surgical Inc. trades at a P/E ratio of -0.15, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 0.75 suggesting the stock is closer to book value. The P/FCF stands at -0.16, also above market averages.